共 25 条
A rationally designed peptide IA-2-P2 against type 1 diabetes in streptozotocin-induced diabetic mice
被引:3
作者:
Shen, Lili
[1
]
Lu, Shiping
[1
]
Huang, Dongcheng
[1
]
Li, Guoliang
[1
]
Liu, Kunfeng
[1
]
Cao, Rongyue
[1
]
Zong, Li
[2
]
Jin, Liang
[1
]
Wu, Jie
[1
]
机构:
[1] China Pharmaceut Univ, Sch Life Sci & Technol, Minigene Pharm Lab, Nanjing 210000, Peoples R China
[2] China Pharmaceut Univ, Inst Pharmaceut, Sch Pharm, Nanjing, Jiangsu, Peoples R China
基金:
中国国家自然科学基金;
关键词:
Type;
1;
diabetes;
peptide P277;
insulinoma antigen-2;
atherosclerosis;
HEAT-SHOCK-PROTEIN;
BETA-CELL FUNCTION;
PHASE-II TRIAL;
DOUBLE-BLIND;
DIAPEP277;
VACCINATION;
THERAPY;
ATHEROSCLEROSIS;
AUTOANTIGEN;
MELLITUS;
D O I:
10.1177/1479164116664189
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Recent studies have investigated the potential of type 1 diabetes mellitus-related autoantigens, such as heat shock protein 60, to induce immunological tolerance or to suppress the immune response. A functional 24-residue peptide derived from heat shock protein 60 (P277) has shown anti-type 1 diabetes mellitus potential in experimental animals and in clinical studies, but it also carries a potential atherogenic effect. In this study, we have modified P277 to retain an anti-type 1 diabetes mellitus effect and minimize the atherogenic potential by replacing the P277 B epitope with another diabetes-associated autoantigen, insulinoma antigen-2 (IA-2), to create the fusion peptide IA-2-P2. In streptozotocin-induced diabetic C57BL/6J mice, the IA-2-P2 peptide displayed similar anti-diabetic effects to the control P277 peptide. Also, the IA-2-P2 peptide did not show atherogenic activity in a rabbit model. Our findings indicate the potential of IA-2-P2 as a promising vaccine against type 1 diabetes mellitus.
引用
收藏
页码:184 / 190
页数:7
相关论文